Takeda, Yoshiyu <br/><br/>
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.  [electronic resource] 

 -  Circulation  Feb 2002 
 - 677-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/hc0602.104675  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldosterone<br/>Animals<br/>Anti-Arrhythmia Agents--pharmacology<br/>Antihypertensive Agents--pharmacology<br/>Atrial Natriuretic Factor--genetics<br/>Body Weight<br/>Calcineurin--metabolism<br/>Calcineurin Inhibitors<br/>Cardiomegaly--chemically induced<br/>Collagen Type III--metabolism<br/>Cyclosporine--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Fibrosis--chemically induced<br/>Heart--drug effects<br/>Immunosuppressive Agents--pharmacology<br/>Losartan--pharmacology<br/>Male<br/>Mineralocorticoids<br/>Myocardium--metabolism<br/>Nephrectomy<br/>Organ Size--drug effects<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Inbred WKY<br/>Sodium Chloride, Dietary<br/>Tacrolimus--pharmacology